A comprehensive brain imaging study has overturned prevailing theories about long COVID’s neurological mechanisms, finding no evidence of widespread brain inflammation in patients with persistent symptoms. Instead, researchers discovered that the most severe long COVID symptoms correlated with heightened activity in brain regions controlling mood and emotion, suggesting fundamentally different pathways than previously assumed.
Brain Activity Patterns in Long COVID Patients
Regional brain activity differences compared to healthy controls, measured by neuroimaging
mood-related activity
processing changes
inflammation markers
Source: ScienceDaily Study Analysis, 2026 | Georgian Medical Journal News
Neuroinflammation Theory Fails Key Test
The study, conducted using advanced brain imaging techniques, systematically examined the brains of long COVID patients experiencing persistent neurological symptoms including brain fog, fatigue, and cognitive difficulties. Contrary to widespread scientific expectations, researchers found no detectable signs of the neuroinflammation that many had hypothesized as the primary driver of these debilitating symptoms.
This finding represents a significant shift in understanding long COVID’s neurological impact. Previous research had suggested that ongoing inflammatory processes in the brain might explain the persistent cognitive symptoms experienced by millions of long COVID patients worldwide. The absence of such inflammation signals forces researchers to reconsider fundamental assumptions about the condition’s mechanisms.
Instead of inflammation, the brain scans revealed heightened activity in limbic regions associated with emotional processing and mood regulation. This pattern suggests that long COVID’s neurological symptoms may stem from altered brain function rather than structural damage or inflammatory responses. For related research developments, see our New Studies section.
Mood and Emotion Centers Show Hyperactivity
The most striking discovery emerged from analysis of brain regions involved in emotional processing. Patients with the most severe long COVID symptoms demonstrated significantly increased activity in the amygdala, hippocampus, and prefrontal cortex—areas crucial for mood regulation, memory formation, and emotional responses.
These findings align with clinical observations that many long COVID patients experience heightened anxiety, depression, and emotional lability alongside their physical symptoms. The research suggests these psychological manifestations may not be secondary reactions to chronic illness, but rather direct neurological consequences of COVID-19’s impact on specific brain circuits.
The implications extend beyond understanding long COVID’s mechanisms to potential therapeutic approaches. Current treatment strategies focusing on anti-inflammatory interventions may prove less effective than interventions targeting emotional regulation and mood stabilization. Our Clinical Updates section covers emerging treatment approaches based on these insights.
Implications for Treatment Strategies
The absence of widespread neuroinflammation in long COVID patients necessitates a fundamental reassessment of treatment approaches. Current therapeutic strategies emphasizing anti-inflammatory medications and immunomodulatory interventions may need substantial revision based on this neuroimaging evidence.
Healthcare providers treating long COVID patients may need to shift focus toward interventions targeting emotional regulation, stress management, and mood stabilization. This could include cognitive behavioral therapy, mindfulness-based interventions, and medications specifically addressing the hyperactive emotional processing circuits identified in the brain scans.
The research also raises important questions about biomarker development for long COVID. If inflammation markers prove unreliable indicators of neurological involvement, clinicians will need alternative methods for assessing and monitoring brain-related symptoms in affected patients.
Brain imaging revealed no evidence of widespread neuroinflammation in long COVID patients, but instead showed heightened activity in mood and emotion processing regions, fundamentally challenging current understanding of the condition’s neurological mechanisms.
— Research team, ScienceDaily study (2026)
Key takeaways
- Brain scans found zero evidence of widespread inflammation in long COVID patients despite persistent neurological symptoms
- Most severe symptoms correlated with hyperactivity in brain regions controlling mood and emotional processing
- Current anti-inflammatory treatment approaches may prove less effective than mood-targeted interventions
- Findings suggest long COVID’s psychological symptoms may be direct neurological consequences rather than secondary reactions
Frequently asked questions
Does this mean long COVID brain symptoms are psychological rather than physical?
No, the study shows that brain activity changes are measurable physical alterations in neurological function. The symptoms remain neurologically based, but stem from altered brain circuit function rather than inflammation.
Should patients stop taking anti-inflammatory medications for long COVID?
Patients should consult their healthcare providers before making treatment changes. While this research questions inflammation-focused approaches for neurological symptoms, individual treatment decisions require medical supervision.
What types of treatments might work better based on these findings?
The research suggests that therapies targeting emotional regulation, mood stabilization, and stress management may prove more effective than anti-inflammatory approaches for neurological long COVID symptoms.
These neuroimaging findings represent a pivotal moment in long COVID research, redirecting scientific attention from inflammatory mechanisms toward emotional processing circuits. As researchers develop new therapeutic approaches based on these insights, millions of long COVID patients may finally access more targeted and effective treatments. The study underscores the importance of evidence-based medicine in challenging established assumptions and refining our understanding of complex post-viral conditions.
Source: Scientists thought brain inflammation was driving long COVID but the scans told a different story
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Medically reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD. Spotted an error? Contact the editorial team.
